• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防膳食脂肪引发的生酮作用可减弱BRAF V600E肿瘤的生长。

Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.

作者信息

Xia Siyuan, Lin Ruiting, Jin Lingtao, Zhao Liang, Kang Hee-Bum, Pan Yaozhu, Liu Shuangping, Qian Guoqing, Qian Zhiyu, Konstantakou Evmorfia, Zhang Baotong, Dong Jin-Tang, Chung Young Rock, Abdel-Wahab Omar, Merghoub Taha, Zhou Lu, Kudchadkar Ragini R, Lawson David H, Khoury Hanna J, Khuri Fadlo R, Boise Lawrence H, Lonial Sagar, Lee Benjamin H, Pollack Brian P, Arbiser Jack L, Fan Jun, Lei Qun-Ying, Chen Jing

机构信息

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory, School of Medicine, Emory University, Atlanta, GA 30322, USA.

Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

出版信息

Cell Metab. 2017 Feb 7;25(2):358-373. doi: 10.1016/j.cmet.2016.12.010. Epub 2017 Jan 12.

DOI:10.1016/j.cmet.2016.12.010
PMID:28089569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5299059/
Abstract

Lifestyle factors, including diet, play an important role in the survival of cancer patients. However, the molecular mechanisms underlying pathogenic links between diet and particular oncogenic mutations in human cancers remain unclear. We recently reported that the ketone body acetoacetate selectively enhances BRAF V600E mutant-dependent MEK1 activation in human cancers. Here we show that a high-fat ketogenic diet increased serum levels of acetoacetate, leading to enhanced tumor growth potential of BRAF V600E-expressing human melanoma cells in xenograft mice. Treatment with hypolipidemic agents to lower circulating acetoacetate levels or an inhibitory homolog of acetoacetate, dehydroacetic acid, to antagonize acetoacetate-BRAF V600E binding attenuated BRAF V600E tumor growth. These findings reveal a signaling basis underlying a pathogenic role of dietary fat in BRAF V600E-expressing melanoma, providing insights into the design of conceptualized "precision diets" that may prevent or delay tumor progression based on an individual's specific oncogenic mutation profile.

摘要

包括饮食在内的生活方式因素在癌症患者的生存中起着重要作用。然而,饮食与人类癌症中特定致癌突变之间致病联系的分子机制仍不清楚。我们最近报道,酮体乙酰乙酸盐在人类癌症中选择性增强BRAF V600E突变依赖性的MEK1激活。在此我们表明,高脂肪生酮饮食会增加血清乙酰乙酸盐水平,导致在异种移植小鼠中表达BRAF V600E的人黑色素瘤细胞的肿瘤生长潜力增强。用降血脂药物降低循环中的乙酰乙酸盐水平,或用乙酰乙酸盐的抑制性类似物脱氢乙酸拮抗乙酰乙酸盐与BRAF V600E的结合,可减弱BRAF V600E肿瘤的生长。这些发现揭示了饮食脂肪在表达BRAF V600E的黑色素瘤中致病作用的信号基础,为基于个体特定致癌突变谱来预防或延缓肿瘤进展的概念化“精准饮食”设计提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/41c48c7bc627/nihms838795f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/bd11227d0f87/nihms838795f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/18dd6c7b39cc/nihms838795f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/19d487bd0a31/nihms838795f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/a22819376cba/nihms838795f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/183197935887/nihms838795f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/5bf4e6086fa8/nihms838795f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/41c48c7bc627/nihms838795f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/bd11227d0f87/nihms838795f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/18dd6c7b39cc/nihms838795f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/19d487bd0a31/nihms838795f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/a22819376cba/nihms838795f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/183197935887/nihms838795f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/5bf4e6086fa8/nihms838795f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f29b/5299059/41c48c7bc627/nihms838795f7.jpg

相似文献

1
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.预防膳食脂肪引发的生酮作用可减弱BRAF V600E肿瘤的生长。
Cell Metab. 2017 Feb 7;25(2):358-373. doi: 10.1016/j.cmet.2016.12.010. Epub 2017 Jan 12.
2
HMG-CoA synthase 1 is a synthetic lethal partner of BRAF in human cancers.HMG-CoA合酶1是人类癌症中BRAF的合成致死伴侣。
J Biol Chem. 2017 Jun 16;292(24):10142-10152. doi: 10.1074/jbc.M117.788778. Epub 2017 May 3.
3
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.致癌性BRAF V600E引发的代谢重编程将生酮途径与BRAF-MEK1信号传导联系起来。
Mol Cell. 2015 Aug 6;59(3):345-358. doi: 10.1016/j.molcel.2015.05.037. Epub 2015 Jul 2.
4
The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells.膳食补充剂硫酸软骨素 4 硫酸盐对 BRAF V600E 黑色素瘤细胞具有致癌基因特异性促肿瘤作用。
Mol Cell. 2018 Mar 15;69(6):923-937.e8. doi: 10.1016/j.molcel.2018.02.010.
5
Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.吲哚 - 3 - 甲醇对致癌性BRAF活性的抑制作用会破坏小眼畸形相关转录因子的表达并阻止黑色素瘤细胞增殖。
Mol Carcinog. 2017 Jan;56(1):49-61. doi: 10.1002/mc.22472. Epub 2016 Feb 15.
6
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy.鉴定 BRAF V600E 突变和 EZH2 增益在黑色素瘤中的共存,为联合治疗提供了有前景的靶点。
J Transl Med. 2017 Dec 4;15(1):243. doi: 10.1186/s12967-017-1344-z.
7
Pharmacokinetic Evaluation of [C]CEP-32496 in Nude Mice Bearing BRAF Mutation-Induced Melanomas.携带BRAF突变诱导黑色素瘤的裸鼠中[C]CEP - 32496的药代动力学评估
Mol Imaging. 2018 Jan-Dec;17:1536012118795952. doi: 10.1177/1536012118795952.
8
Discovery of a novel pan-RAF inhibitor with potent anti-tumor activity in preclinical models of BRAF mutant cancer.在BRAF突变癌症临床前模型中发现一种具有强大抗肿瘤活性的新型泛RAF抑制剂。
Life Sci. 2017 Aug 15;183:37-44. doi: 10.1016/j.lfs.2017.06.021. Epub 2017 Jun 21.
9
Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.BRAF 抑制剂 vemurafenib 在 BRAF 突变型结直肠癌的临床前模型中的抗肿瘤活性。
Cancer Res. 2012 Feb 1;72(3):779-89. doi: 10.1158/0008-5472.CAN-11-2941. Epub 2011 Dec 16.
10
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.肿瘤靶向性鼠伤寒沙门氏菌A1-R在患者来源的原位异种移植(PDOX)裸鼠模型中使携带BRAF-V600E突变的黑色素瘤对维莫非尼敏感。
J Cell Biochem. 2017 Aug;118(8):2314-2319. doi: 10.1002/jcb.25886. Epub 2017 Apr 25.

引用本文的文献

1
Hyperlipidemia drives tumor growth in a mouse model of obesity-accelerated breast cancer growth.在肥胖加速乳腺癌生长的小鼠模型中,高脂血症会促进肿瘤生长。
Cancer Metab. 2025 Aug 28;13(1):39. doi: 10.1186/s40170-025-00407-0.
2
Clinical characteristics of 27 children with febrile infection-related epilepsy syndrome in a single center.单中心27例发热感染相关癫痫综合征患儿的临床特征
Pediatr Discov. 2024 Jun 9;2(2):e84. doi: 10.1002/pdi3.84. eCollection 2024 Jun.
3
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View.黑色素瘤中的代谢重编程:表观遗传学视角

本文引用的文献

1
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.致癌性BRAF V600E引发的代谢重编程将生酮途径与BRAF-MEK1信号传导联系起来。
Mol Cell. 2015 Aug 6;59(3):345-358. doi: 10.1016/j.molcel.2015.05.037. Epub 2015 Jul 2.
2
Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay.使用细胞热转移分析监测细胞和组织中的药物靶标结合。
Science. 2013 Jul 5;341(6141):84-7. doi: 10.1126/science.1233606.
3
Paradoxical oncogenesis--the long-term effects of BRAF inhibition in melanoma.
Pharmaceuticals (Basel). 2025 Jun 6;18(6):853. doi: 10.3390/ph18060853.
4
Deciphering Colorectal Cancer-Hepatocyte Interactions: A Multiomics Platform for Interrogation of Metabolic Crosstalk in the Liver-Tumor Microenvironment.解析结直肠癌与肝细胞的相互作用:用于探究肝肿瘤微环境中代谢串扰的多组学平台
Int J Mol Sci. 2025 Feb 25;26(5):1976. doi: 10.3390/ijms26051976.
5
Extracellular vesicle-mediated gene therapy targets BRAF-mutant colorectal cancer by inhibiting the MEK1/2-ERK1/2 pathway.细胞外囊泡介导的基因疗法通过抑制MEK1/2-ERK1/2途径靶向BRAF突变型结直肠癌。
J Nanobiotechnology. 2025 Feb 20;23(1):129. doi: 10.1186/s12951-025-03205-4.
6
Differential Effects of High-Fiber and Low-Fiber Diets on Antitumor Immunity and Colon Tumor Progression in a Murine Model.高纤维和低纤维饮食对小鼠模型抗肿瘤免疫和结肠肿瘤进展的不同影响
Cancer Prev Res (Phila). 2025 Apr 1;18(4):223-234. doi: 10.1158/1940-6207.CAPR-24-0159.
7
Comprehensive Overview of Ketone Bodies in Cancer Metabolism: Mechanisms and Application.癌症代谢中酮体的全面概述:机制与应用
Biomedicines. 2025 Jan 16;13(1):210. doi: 10.3390/biomedicines13010210.
8
Deciphering Colorectal Cancer-Hepatocyte Interactions: A Multiomic Platform for Interrogation of Metabolic Crosstalk in the Liver-Tumor Microenvironment.解析结直肠癌与肝细胞的相互作用:用于探究肝脏-肿瘤微环境中代谢串扰的多组学平台
bioRxiv. 2024 Dec 14:2024.12.06.627264. doi: 10.1101/2024.12.06.627264.
9
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.胶质母细胞瘤生酮代谢疗法的临床研究框架提案
BMC Med. 2024 Dec 5;22(1):578. doi: 10.1186/s12916-024-03775-4.
10
Ketogenesis promotes triple-negative breast cancer metastasis via calpastatin β-hydroxybutyrylation.酮体生成通过钙蛋白酶抑制蛋白β-羟丁酸酰化促进三阴性乳腺癌转移。
Lipids Health Dis. 2024 Nov 12;23(1):371. doi: 10.1186/s12944-024-02364-x.
矛盾性致癌作用——BRAF 抑制剂在黑色素瘤中的长期效应。
Nat Rev Clin Oncol. 2013 Jul;10(7):390-9. doi: 10.1038/nrclinonc.2013.83. Epub 2013 May 28.
4
Obesity and melanoma: exploring molecular links.肥胖与黑色素瘤:探索分子关联。
J Cell Biochem. 2013 Sep;114(9):1955-61. doi: 10.1002/jcb.24549.
5
A variant in FTO shows association with melanoma risk not due to BMI.FTO 基因变异与黑色素瘤风险相关,但与 BMI 无关。
Nat Genet. 2013 Apr;45(4):428-32, 432e1. doi: 10.1038/ng.2571. Epub 2013 Mar 3.
6
Update on the targeted therapy of melanoma.黑色素瘤的靶向治疗进展。
Curr Treat Options Oncol. 2013 Jun;14(2):280-92. doi: 10.1007/s11864-013-0226-8.
7
Ketone body metabolism and cardiovascular disease.酮体代谢与心血管疾病。
Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1060-76. doi: 10.1152/ajpheart.00646.2012. Epub 2013 Feb 8.
8
Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies.肥胖与恶性黑色素瘤风险:队列研究和病例对照研究的荟萃分析。
Eur J Cancer. 2013 Feb;49(3):642-57. doi: 10.1016/j.ejca.2012.08.028. Epub 2012 Nov 29.
9
Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.磷酸甘油酸变位酶 1 协调糖酵解和生物合成以促进肿瘤生长。
Cancer Cell. 2012 Nov 13;22(5):585-600. doi: 10.1016/j.ccr.2012.09.020.
10
Vemurafenib: the first drug approved for BRAF-mutant cancer.威罗菲尼:首个获批准用于 BRAF 突变型癌症的药物。
Nat Rev Drug Discov. 2012 Nov;11(11):873-86. doi: 10.1038/nrd3847. Epub 2012 Oct 12.